New Study Recommends PSA Screening for Prostate CancerThe new guidelines now say men between the ages of 55 and 69 should talk with their primary care physician about whether or not to have a PSA test.
Prostate Cancer Cases Increase Within a DecadeSome experts blame more lax screening guidelines.
Health Officials Urge Prostate Cancer Patients to Screen BRCA GeneWashington University and Barnes Jewish Urologist Dr. Gerald Andriole says men with advanced prostate cancer are being urged to be screened for the BRCA gene.
SEC Football Promoting Prostate Cancer AwarenessMizzou's game is September 5th against SEMO
Men with Certain Pattern of Baldness Have Increased Risk of Prostate CancerA new study finds men with a certain pattern of baldness by the age of 45 had a 39 percent increased risk of aggressive prostate cancer versus men with no baldness.
Chemo Drug Extends Life of Patients with Advanced Prostate CancerA cheap chemotherapy drug tested in St. Louis has been found to extend life for more than a year for men with whose prostate cancer has spread.
WashU Researchers Discover Improved Prostate Cancer TestingUp until now, ultrasound biopsies didn't always target the cancer infected part of the prostate, leading to a hit-or-miss approach to the size or aggressiveness of the cancer.
Overnight America: September 2nd, 2013 - Mark Schulz, Paul Williams
Study Seeks to Redefine Cancer; Local Expert WearyThe researchers argue that not only does the definition of cancer need to change, but in some cases, the word should be dropped from many common diagnoses.
New Treatment Option For Prostate Cancer Patients The Siteman Cancer Center is now one of just five in the U.S. offering a new treatment for prostate cancer patients.
Some Discouraged From Prostate Cancer Screening Under New GuidelinesThe American Urological Association now supports new guidelines which state routine screening is no longer recommended for men who are at average risk for the disease.
FDA Expands Approval of Prostate Cancer DrugThe typical patient taking Zytiga survived five months longer than the patient taking a fake pill, or placebo.